Skip to main content

Closed

AYTU: Aytu BioPharma, Inc. Financial Statements & Revenue | finqOS

Healthcare · Drug Manufacturers - Specialty & Generic

52W Range

41thpctl

Volume

1.98×avg

Market Cap

23.94MUSD

P/E Ratio

-0.5TTM

Div Yield

-ann

Aytu BioPharma, Inc.

AYTUNASDAQ Capital Market·USD·Closed

Aytu BioPharma, Inc.

AYTUNASDAQ·USD·Closed

$2.23

+3.72%

$2.23

+$0.08 (3.72%)

52W Range

41thpctl

Volume

1.98×avg

Mkt Cap

23.94MUSD

P/E

-0.5TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings